176 related articles for article (PubMed ID: 9790194)
1. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor.
Kato Y; Tapping RI; Huang S; Watson MH; Ulevitch RJ; Lee JD
Nature; 1998 Oct; 395(6703):713-6. PubMed ID: 9790194
[TBL] [Abstract][Full Text] [Related]
2. Bone and Extracellular Signal-Related Kinase 5 (ERK5).
Wen L; Liu Z; Zhou L; Liu Z; Li Q; Geng B; Xia Y
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785963
[TBL] [Abstract][Full Text] [Related]
3. ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.
Guillén-Pérez YM; Ortiz-Ruiz MJ; Márquez J; Pandiella A; Esparís-Ogando A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542254
[TBL] [Abstract][Full Text] [Related]
4. The significance of ERK5 catalytic-independent functions in disease pathways.
Le NT
Front Cell Dev Biol; 2023; 11():1235217. PubMed ID: 37601096
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells.
Hwang J; Moon H; Kim H; Kim KY
Curr Issues Mol Biol; 2023 Jul; 45(7):6154-6169. PubMed ID: 37504304
[TBL] [Abstract][Full Text] [Related]
6. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
Sánchez-Fdez A; Matilla-Almazán S; Del Carmen S; Abad M; Arconada-Luque E; Jiménez-Suárez J; Chinchilla-Tábora LM; Ruíz-Hidalgo MJ; Sánchez-Prieto R; Pandiella A; Esparís-Ogando A
Exp Mol Med; 2023 Jun; 55(6):1247-1257. PubMed ID: 37332046
[TBL] [Abstract][Full Text] [Related]
7. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis.
Abe JI; Imanishi M; Li S; Zhang A; Ko KA; Samanthapudi VSK; Lee LL; Bojorges AP; Gi YJ; Hobbs BP; Deswal A; Herrmann J; Lin SH; Chini EN; Shen YH; Schadler KL; Nguyen TH; Gupte AA; Reyes-Gibby C; Yeung SJ; Abe RJ; Olmsted-Davis EA; Krishnan S; Dantzer R; Palaskas NL; Cooke JP; Pownall HJ; Yoshimoto M; Fujiwara K; Hamilton DJ; Burks JK; Wang G; Le NT; Kotla S
Circ Res; 2023 Jun; 133(1):25-44. PubMed ID: 37264926
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
Tusa I; Menconi A; Tubita A; Rovida E
Cells; 2023 Apr; 12(8):. PubMed ID: 37190064
[TBL] [Abstract][Full Text] [Related]
9. DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer.
Im JY; Kang MJ; Kim BK; Won M
Exp Mol Med; 2023 May; 55(5):879-885. PubMed ID: 37121974
[TBL] [Abstract][Full Text] [Related]
10. Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.
Miller DC; Harnor SJ; Martin MP; Noble RA; Wedge SR; Cano C
J Med Chem; 2023 Apr; 66(7):4491-4502. PubMed ID: 37002872
[TBL] [Abstract][Full Text] [Related]
11. VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells.
Mondru AK; Aljasir MA; Alrumayh A; Nithianandarajah GN; Ahmed K; Muller J; Goldring CEP; Wilm B; Cross MJ
Cells; 2023 Mar; 12(6):. PubMed ID: 36980305
[TBL] [Abstract][Full Text] [Related]
12. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.
Diéguez-Martínez N; Espinosa-Gil S; Yoldi G; Megías-Roda E; Bolinaga-Ayala I; Viñas-Casas M; Gorgisen G; Domingo-Ortí I; Pérez-Montoyo H; Bayascas JR; Colas E; Dolcet X; Lizcano JM
Cell Mol Life Sci; 2022 Sep; 79(10):524. PubMed ID: 36123565
[TBL] [Abstract][Full Text] [Related]
13. Studying molecular signaling in major angiogenic diseases.
Nathan J; Shameera R; Palanivel G
Mol Cell Biochem; 2022 Oct; 477(10):2433-2450. PubMed ID: 35581517
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.
Monti M; Celli J; Missale F; Cersosimo F; Russo M; Belloni E; Di Matteo A; Lonardi S; Vermi W; Ghigna C; Giurisato E
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053510
[TBL] [Abstract][Full Text] [Related]
15. Irradiation with a red light-emitting diode enhances the proliferation of stem cells of apical papilla via the ERK5 signalling pathway.
Shu C; Hou L; Chen Q; Zhu T; Yang J; Luo X; Su Y; Wang Y
Lasers Med Sci; 2022 Jun; 37(4):2259-2268. PubMed ID: 35022873
[TBL] [Abstract][Full Text] [Related]
16. ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress.
Gámez-García A; Bolinaga-Ayala I; Yoldi G; Espinosa-Gil S; Diéguez-Martínez N; Megías-Roda E; Muñoz-Guardiola P; Lizcano JM
Front Cell Dev Biol; 2021; 9():742049. PubMed ID: 34805151
[TBL] [Abstract][Full Text] [Related]
17. ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.
Ortega-Muelas M; Roche O; Fernández-Aroca DM; Encinar JA; Albandea-Rodríguez D; Arconada-Luque E; Pascual-Serra R; Muñoz I; Sánchez-Pérez I; Belandia B; Ruiz-Hidalgo MJ; Sánchez-Prieto R
J Cell Mol Med; 2021 Nov; 25(22):10591-10603. PubMed ID: 34655447
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer.
Kavarthapu R; Anbazhagan R; Dufau ML
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572912
[TBL] [Abstract][Full Text] [Related]
19. Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.
Sánchez-Fdez A; Re-Louhau MF; Rodríguez-Núñez P; Ludeña D; Matilla-Almazán S; Pandiella A; Esparís-Ogando A
NPJ Precis Oncol; 2021 Aug; 5(1):78. PubMed ID: 34404896
[TBL] [Abstract][Full Text] [Related]
20. The MEK5/ERK5 Pathway in Health and Disease.
Paudel R; Fusi L; Schmidt M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
